These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 16024646)
1. Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers. Kloor M; Becker C; Benner A; Woerner SM; Gebert J; Ferrone S; von Knebel Doeberitz M Cancer Res; 2005 Jul; 65(14):6418-24. PubMed ID: 16024646 [TBL] [Abstract][Full Text] [Related]
2. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the immune escape phenotype of human gastric cancers with and without high-frequency microsatellite instability. Hirata T; Yamamoto H; Taniguchi H; Horiuchi S; Oki M; Adachi Y; Imai K; Shinomura Y J Pathol; 2007 Apr; 211(5):516-523. PubMed ID: 17318812 [TBL] [Abstract][Full Text] [Related]
4. MUTYH-associated polyposis carcinomas frequently lose HLA class I expression - a common event amongst DNA-repair-deficient colorectal cancers. de Miranda NF; Nielsen M; Pereira D; van Puijenbroek M; Vasen HF; Hes FJ; van Wezel T; Morreau H J Pathol; 2009 Sep; 219(1):69-76. PubMed ID: 19462419 [TBL] [Abstract][Full Text] [Related]
5. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact. Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376 [TBL] [Abstract][Full Text] [Related]
6. Beta2-microglobulin mutations in microsatellite unstable colorectal tumors. Kloor M; Michel S; Buckowitz B; Rüschoff J; Büttner R; Holinski-Feder E; Dippold W; Wagner R; Tariverdian M; Benner A; Schwitalle Y; Kuchenbuch B; von Knebel Doeberitz M Int J Cancer; 2007 Jul; 121(2):454-8. PubMed ID: 17373663 [TBL] [Abstract][Full Text] [Related]
7. HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. Dierssen JW; de Miranda NF; Ferrone S; van Puijenbroek M; Cornelisse CJ; Fleuren GJ; van Wezel T; Morreau H BMC Cancer; 2007 Feb; 7():33. PubMed ID: 17316446 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289 [TBL] [Abstract][Full Text] [Related]
9. Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes. Michel S; Linnebacher M; Alcaniz J; Voss M; Wagner R; Dippold W; Becker C; von Knebel Doeberitz M; Ferrone S; Kloor M Int J Cancer; 2010 Aug; 127(4):889-98. PubMed ID: 20013806 [TBL] [Abstract][Full Text] [Related]
10. Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells. Schwitalle Y; Linnebacher M; Ripberger E; Gebert J; von Knebel Doeberitz M Cancer Immun; 2004 Nov; 4():14. PubMed ID: 15563124 [TBL] [Abstract][Full Text] [Related]
11. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179 [TBL] [Abstract][Full Text] [Related]
12. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Banerjea A; Ahmed S; Hands RE; Huang F; Han X; Shaw PM; Feakins R; Bustin SA; Dorudi S Mol Cancer; 2004 Aug; 3():21. PubMed ID: 15298707 [TBL] [Abstract][Full Text] [Related]
13. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355 [TBL] [Abstract][Full Text] [Related]
14. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726 [TBL] [Abstract][Full Text] [Related]
15. Tumour-infiltrating lymphocytes in colorectal cancer with microsatellite instability are activated and cytotoxic. Phillips SM; Banerjea A; Feakins R; Li SR; Bustin SA; Dorudi S Br J Surg; 2004 Apr; 91(4):469-75. PubMed ID: 15048750 [TBL] [Abstract][Full Text] [Related]
16. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism? Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610 [TBL] [Abstract][Full Text] [Related]
17. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847 [TBL] [Abstract][Full Text] [Related]
19. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633 [TBL] [Abstract][Full Text] [Related]
20. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumor-specific immune responses and survival. Lou Y; Vitalis TZ; Basha G; Cai B; Chen SS; Choi KB; Jeffries AP; Elliott WM; Atkins D; Seliger B; Jefferies WA Cancer Res; 2005 Sep; 65(17):7926-33. PubMed ID: 16140964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]